[CLINICAL EXPERIMENTATION WITH OPTANOX].
D000437:Alcoholism; D001463:Barbiturates; D001659:Biliary Tract; D002318:Cardiovascular Diseases; D002763:Cholecystectomy; D005743:Gastrectomy; D005762:Gastroenterology; D006471:Gastrointestinal Hemorrhage; D006470:Hemorrhage; D006801:Humans; D008103:Liver Cirrhosis; D008171:Lung Diseases; D009369:Neoplasms; D009393:Nephritis; D010437:Peptic Ulcer; D010919:Placebos; D011183:Postoperative Complications; D007319:Sleep Initiation and Maintenance Disorders; D014116:Toxicology
D001463:Barbiturates; D010919:Placebos
ALCOHOLISM; BARBITURATES; BILIARY TRACT; CARDIOVASCULAR DISEASES; CHOLECYSTECTOMY; GASTRECTOMY; GASTROENTEROLOGY; HEMORRHAGE, GASTROINTESTINAL; INSOMNIA; LIVER CIRRHOSIS; LUNG DISEASES; NEOPLASMS; NEPHRITIS; PEPTIC ULCER; PLACEBOS; POSTOPERATIVE COMPLICATIONS; TOXICOLOGIC REPORT